Executive Committee

Mitchell Krucoff, MD
(Co-Chair)
Professor of Medicine
Duke University School of Medicine
Director, Cardiovascular Devices Unit
Duke University Medical Center
Duke Clinical Research Institute

Ignacio Rodriguez, MD
(Co-Chair)

Director, Clinical Safety
Roche

John K. Finkle, MD
Global Head, Safety Evaluation & Risk Management
Development Products
GlaxoSmithKline

Norman Stockbridge, MD, PhD
Director, Division of Cardiovascular
Food and Drug Administration

David Strauss, MD, PhD
Director, Division of Applied Regulatory Science
Food and Drug Administration

Philip Sager, MD
Adjunct Professor of Medicine
Stanford University School of Medicine

Cindy Green, PhD
Assistant Professor of Biostatistics
Duke University
Duke Clinical Research Institute

Colette Strnadova, PhD
Senior Scientific Advisor
Health Products and Food
Health Canada

Theressa Wright, MD 
Volunteer Clinical Assistant Professor of Medicine
Indiana University School of Medicine

Rick Turner, PhD, DSc
Senior Scientific Director
IQVIA

Mary Jane Geiger, MD, PhD
Vice President, TA Lead, Cardiovascular
Drug Development Services Clinical Research Service
ICON

Gary Gintant, PhD
Research Fellow
Integrative Pharm., Integrated Science and Technology
AbbVie

Kaori Shinagawa, MD, PhD
Senior Scientist, Clinical Medicine
Pharmaceutical and Medical Devices Agency

Peter Kowey, MD
Professor of Cardiology
Jefferson Medical College
Lankenau Hospital and Medical Research Center

Thomas Todaro, MD, JD
Vice President, Medial Affairs
Cardiovascular Disease
Medpace

Valarie Morrow, MD
Project Manager
Duke Clinical Research Institute

Jonathan Seltzer, MD, MBA, MA
President, ACI Clinical
Director, Clinical Research, Lankenau Heart Institute